122 related articles for article (PubMed ID: 20875619)
1. Sepsis worsening vascular hyporeactivity of the superior mesenteric artery in portal vein-ligated rats.
Liao WC; Hou MC; Wang GJ; Yu KW; Lee FY; Lin HC; Lee SD
J Chin Med Assoc; 2010 Sep; 73(9):462-70. PubMed ID: 20875619
[TBL] [Abstract][Full Text] [Related]
2. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
5. Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats.
Sieber CC; Lee FY; Groszmann RJ
Hepatology; 1996 May; 23(5):1218-23. PubMed ID: 8621156
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE
Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
[TBL] [Abstract][Full Text] [Related]
7. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
Heinemann A; Stauber RE
J Hepatol; 1996 Jun; 24(6):739-46. PubMed ID: 8835750
[TBL] [Abstract][Full Text] [Related]
8. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats.
Sogni P; Sabry S; Moreau R; Gadano A; Lebrec D; Dinh-Xuan AT
J Hepatol; 1996 Apr; 24(4):487-90. PubMed ID: 8738736
[TBL] [Abstract][Full Text] [Related]
9. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
[TBL] [Abstract][Full Text] [Related]
10. Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats.
Karatapanis S; McCormick PA; Kakad S; Chin JK; Islam M; Jeremy J; Harry D; McIntyre N; Burroughs AK; Jacobs M
Hepatology; 1994 Dec; 20(6):1516-21. PubMed ID: 7527005
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
12. iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats.
Kajita M; Murata T; Horiguchi K; Iizuka M; Hori M; Ozaki H
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H1021-31. PubMed ID: 21193589
[TBL] [Abstract][Full Text] [Related]
13. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats.
Heinemann A; Stauber RE
Eur J Pharmacol; 1995 May; 278(1):87-90. PubMed ID: 7545125
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
[TBL] [Abstract][Full Text] [Related]
15. Modulation of hypoxic pulmonary vasoconstriction is time and nitric oxide dependent in a peritonitis model of sepsis.
Fischer LG; Freise H; Hilpert JH; Wendholt D; Lauer S; Van Aken H; Sielenkämper AW
Intensive Care Med; 2004 Sep; 30(9):1821-8. PubMed ID: 15375651
[TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of nitric oxide increases the collateral vascular responsiveness to vasopressin in portal hypertensive rats.
Huang HC; Wang SS; Chan CC; Lee FY; Chang FY; Lin HC; Hou MC; Tai CC; Lai IN; Lee SD
J Hepatol; 2004 Feb; 40(2):234-8. PubMed ID: 14739093
[TBL] [Abstract][Full Text] [Related]
17. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis.
Fernández M; García-Pagán JC; Casadevall M; Mourelle MI; Piqué JM; Bosch J; Rodés J
Gastroenterology; 1996 May; 110(5):1529-35. PubMed ID: 8613060
[TBL] [Abstract][Full Text] [Related]
19. Neurally-mediated vasodilatation in normal and portal hypertensive rats: role of nitric oxide and calcitonin gene-related peptide.
Moll-Kaufmann C; Sumanovski LT; Sieber CC
J Hepatol; 1998 Jun; 28(6):1031-6. PubMed ID: 9672180
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of propranolol improves vascular contractile responsiveness in portal hypertensive rats.
Huang YT; Lin HC; Tsai JF; Hou MC; Hong CY
Eur J Clin Invest; 1997 Jul; 27(7):550-5. PubMed ID: 9263740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
